
    
      Participants 18 to < 65 years of age will be randomized to receive a dose of either Fluzone
      or Fluzone Intradermal vaccine and participants â‰¥ 65 years of age will be randomized to
      receive a dose of Fluzone or Fluzone High-Dose vaccine. All participants will be followed up
      for safety and immunogenicity. The duration of participation in the trial will be
      approximately 21 days.
    
  